The Pharmacy Times® Reimbursement resource center provides clinical news and articles, information about reimbursement for clinical pharmacy services.
What can we help you find?
The changes, finalized today, are generally effective for the 2022 plan year and will potentially lower enrollee cost sharing on some of the most expensive prescription drugs.
Katea Ravega, a partner at Quarles and Brady LLP, discussed the recent Supreme Court ruling in Rutledge v. PCMA and what it could mean for the future of states’ legislation around PBMs.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Supreme Court ruling clears the way for states to pass laws that protect pharmacies from predatory reimbursement practices by PBMs.
Supreme Court decision establishes that states do have the right to regulate pharmacy benefit managers in managed care organizations.
If current drug pricing trends continue, cost-related non-adherence to therapy will result in the premature deaths of 112,000 Medicare beneficiaries per year.
Pharmacists must demonstrate value to achieve success when implementing new services and especially when establishing an entirely new practice.
Medicaid expansion has helped to increase annual checkups among low income individuals.
The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.
Trends and comfort levels have changed among consumers, pharmacies, and payers from 2019 to 2020 as it relates to pharmacist-provided services and value-based performance programs.
Throughout the pandemic, pharmacists have played a critical role in the COVID-19 response in several ways